3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
18
Liver Neoplasms
3
Recurrence
2
Uveal Melanoma
1
Sarcoma
1
Recurrence Hepatocellular Carcinoma
1
Pleural Neoplasms
1
Pancreatic Adenocarcinoma
1
Neoplastic Cells, Circulating
1
Neoplasm Recurrence, Local
1
Mediastinal Neoplasms
1
Malignant Neoplasm in the Head and Neck
1
Lung Neoplasms
1
Lung Metastases
1
Liver Cirrhosis
1
HCC
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Radiotherapy
3
Cisplatin
2
tislelizumab
1
pembrolizumab
1
Tamoxifen
1
TP protocol
1
Spinal Puncture
1
Radiosurgery
1
Paclitaxel
1
Oxaliplatin
1
Irinotecan
1
Gemcitabine
1
Gadolinium
1
Fluorouracil
1
Ethiodized Oil
1
Cetuximab
1
Carboplatin
1
Blood Specimen Collection
1
Anesthesia, General
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasm Recurrence, Local
×
Ethiodized Oil
×
Clear all
NCT00470340
2011-05-05
GEMOXIAL
Assistance Publique - Hôpitaux de Paris
Phase 3
Terminated
263 enrolled